SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

VALGIMIGLI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.874
AS - Asia 1.407
EU - Europa 651
SA - Sud America 269
AF - Africa 23
OC - Oceania 2
Totale 5.226
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.821
SG - Singapore 610
CN - Cina 409
BR - Brasile 219
DE - Germania 145
HK - Hong Kong 131
UA - Ucraina 131
VN - Vietnam 111
GB - Regno Unito 96
TR - Turchia 60
IT - Italia 54
RU - Federazione Russa 50
SE - Svezia 43
FI - Finlandia 42
MX - Messico 28
CA - Canada 21
PL - Polonia 18
AR - Argentina 17
FR - Francia 17
ID - Indonesia 17
IN - India 16
ZA - Sudafrica 15
BD - Bangladesh 12
JP - Giappone 12
BE - Belgio 11
EC - Ecuador 10
CO - Colombia 9
ES - Italia 8
IQ - Iraq 7
AL - Albania 6
IE - Irlanda 6
NL - Olanda 6
LT - Lituania 5
VE - Venezuela 5
CZ - Repubblica Ceca 4
AT - Austria 3
CL - Cile 3
JO - Giordania 3
PK - Pakistan 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
DZ - Algeria 2
EG - Egitto 2
MA - Marocco 2
OM - Oman 2
PY - Paraguay 2
RO - Romania 2
UY - Uruguay 2
AU - Australia 1
BO - Bolivia 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GR - Grecia 1
IL - Israele 1
IR - Iran 1
IS - Islanda 1
JM - Giamaica 1
KE - Kenya 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
NZ - Nuova Zelanda 1
PE - Perù 1
PS - Palestinian Territory 1
QA - Qatar 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 5.226
Salva come PNG Salva come JPEG
Città #
Ashburn 309
Singapore 301
Woodbridge 290
Fairfield 286
Beijing 171
Santa Clara 166
Ann Arbor 164
Chandler 153
Houston 136
Jacksonville 133
Hong Kong 131
Seattle 118
Wilmington 107
New York 69
Cambridge 65
Los Angeles 55
Ho Chi Minh City 47
Princeton 43
Dallas 38
Izmir 37
Nanjing 37
San Diego 29
Bremen 25
Munich 24
Boardman 21
Buffalo 21
Mexico City 21
Shanghai 21
São Paulo 21
Hanoi 20
Milan 18
Falkenstein 16
Jakarta 16
Warsaw 16
Chicago 14
Shenyang 14
Jiaxing 13
Phoenix 13
Redwood City 13
Helsinki 12
Brussels 11
Dearborn 11
London 11
Nanchang 11
Tianjin 11
Tokyo 11
Bologna 10
Brooklyn 10
Changsha 10
Jinan 9
Moscow 9
Boston 8
Hefei 8
Rio de Janeiro 8
Toronto 8
Washington 8
Denver 7
Ferrara 7
Leawood 7
Montreal 7
Nuremberg 7
San Mateo 7
Stockholm 7
Auburn Hills 6
Johannesburg 6
Norwalk 6
Orem 6
Ankara 5
Baghdad 5
Charlotte 5
Curitiba 5
Dong Ket 5
Falls Church 5
Manchester 5
Mountain View 5
Poplar 5
San Francisco 5
Zhengzhou 5
Addison 4
Atlanta 4
Augusta 4
Belo Horizonte 4
Chennai 4
Da Nang 4
Dhaka 4
Dublin 4
Hangzhou 4
Mumbai 4
Ninh Bình 4
Philadelphia 4
Quito 4
Turku 4
Agudos 3
Amman 3
Amsterdam 3
Biên Hòa 3
Bragança Paulista 3
Campo Grande 3
Haiphong 3
Indiana 3
Totale 3.566
Salva come PNG Salva come JPEG
Nome #
CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure 227
Poor response to clopidogrel: current and future options for its management 222
Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile 211
Tissue factor and coagulation factor VII levels during acute myocardial infarction: Association with genotype and adverse events 206
High-dose BoluS TiRofibAn and Sirolimus eluting STEnt versus abiciximab and bare metal stent in acute MYocardial infarction (STRATEGY) study - Protocol design and demography of the first 100 patients 199
EURObservational Research Programme: the Chronic Ischaemic Cardiovascular Disease Registry: Pilot phase (CICD-PILOT) 196
Endothelial dysfunction in acute and chronic coronary syndromes: evidence for a pathogenetic role of oxidative stress 171
Hydroxyl radical generation, levels of tumor necrosis factor-alpha, and progression to heart failure after acute myocardial infarction 170
Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: Results from the double-blind, prospective, randomized tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel study 168
Relationship between paraoxonase Q192R gene polymorphism and on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention 167
Sex-specific benefits of sirolimus-eluting stent on long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Insights from the Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study trial 158
Factor XIIIA V34L and Factor XIIIB H95R Gene Polymorphisms: Effects on the Risk of Myocardial Infarction and on Survival. 154
Tissue Factor and Coagulation Factor VII Levels during Acute Myocardial Infarction Contribute to Predict Mortality and re-infarction. 152
Cost-effectiveness of everolimus-eluting versus bare-metal stents in ST-segment elevation myocardial infarction: An analysis from the EXAMINATION randomized controlled trial 144
Cohort profile The ESC-EORP Chronic Ischemic Cardiovascular Disease Long-Term (CICD LT) registry 142
Impact of angiographic coronary artery disease complexity on ischemic and bleeding risks and on the comparative effectiveness of zotarolimus-eluting vs. bare-metal stents in uncertain drug-eluting stent candidates 140
Poor responsiveness to clopidogrel. Drug-specific or class-effect? 139
Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention: Relationship with gene polymorphisms and clinical outcome 137
Long-term clinical outcome based on aspirin and clopidogrel responsiveness status after elective percutaneous coronary intervention: a 3T/2R (tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel) trial substudy 134
Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial 133
Two-year clinical follow-up after sirolimus-eluting versus bare-metal stent implantation assisted by systematic glycoprotein IIb/IIIa Inhibitor Infusion in patients with myocardial infarction: results from the STRATEGY study 133
Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial 131
Two-by-two factorial comparison of high-bolus-dose tirofiban followed by standard infusion versus abciximab and sirolimus-eluting versus bare-metal stent implantation in patients with acute myocardial infarction: design and rationale for the MULTI-STRATEGY trial 124
Poor responsiveness to clopidogrel: drug-specific or class-effect mechanism? Evidence from a clopidogrel-to-ticlopidine crossover study 124
Value of Platelet Reactivity in Predicting Response to Treatment and Clinical Outcome in Patients Undergoing Primary Coronary Intervention. Insights Into the STRATEGY Study 122
Does Large Vessel Size Justify Use of Bare-Metal Stents in Primary Percutaneous Coronary Intervention? Insights From the EXAMINATION Trial 113
Pharmacogenomic Polygenic Response Score Predicts Ischemic Events and Cardiovascular Mortality in Clopidogrel-Treated Patients 112
CD34+ cells mobilization in myocardial infarction: a link with heart failure? 110
High-dose bolus tirofiban and sirolimus-eluting stent versus abciximab and bare metal stent in acute myocardial infarction (STRATEGY) study 105
Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients. 100
Facilitation Through Aggrastat or Cangrelor Bolus and Infusion Over PrasugreL: a MUlticenter Randomized Open-label Trial in PatientS with ST-elevation Myocardial InFarction Referred for PrimAry PercutaneouS InTERvention (FABOLUS FASTER) Trial: Design and Rationale: The FABOLUS FASTER Trial 88
Effects of pre-hospital clopidogrel administration on early and late residual platelet reactivity in ST-segment elevation myocardial infarction patients undergoing primary intervention 84
Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI 84
Acute kidney injury in patients with acute coronary syndrome undergoing invasive management treated with bivalirudin vs. unfractionated heparin: insights from the MATRIX trial 79
Obstructive sleep apnoea syndrome and endothelial function: potential impact of different treatment strategies—meta-analysis of prospective studies 77
Incidence, prognostic impact, and optimal definition of contrast-induced acute kidney injury in consecutive patients with stable or unstable coronary artery disease undergoing percutaneous coronary intervention. insights from the all-comer PRODIGY trial 75
null 61
null 61
Prospective validation of the bleeding academic research consortium classification in the all-comer PRODIGY trial 59
Stable angina pectoris 48
Temporal and genotype-driven variations of factor VII levels in patients with acute myocardial infarction 45
Totale 5.305
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.895
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.895
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021269 0 0 0 0 0 41 19 51 7 51 70 30
2021/2022453 16 51 54 20 23 14 35 27 14 33 49 117
2022/2023362 46 5 19 49 68 58 9 29 47 8 16 8
2023/2024275 25 26 11 8 17 81 10 13 5 8 5 66
2024/2025951 10 26 87 28 126 120 20 19 181 100 133 101
2025/20261.432 284 148 253 336 373 38 0 0 0 0 0 0
Totale 5.305